2003
DOI: 10.1097/01.rlu.0000099808.30653.06
|View full text |Cite
|
Sign up to set email alerts
|

Fluorodeoxyglucose Positron Emission Tomography in the Presence of Cardiac Metastases

Abstract: Physiological fluorodeoxyglucose (FDG) uptake can obscure underlying disease or can even falsely suggest disease in patients undergoing whole-body positron emission tomography (PET) scanning for disease staging. Myocardial uptake in particular can present a problem because of its variability in fasting patients. Nonetheless, we present 2 cases in which FDG PET imaging was effective in identifying metastatic disease to the heart. In 1 case, an FDG PET scan revealed previously unsuspected myocardial metastases. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
9
0

Year Published

2005
2005
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 5 publications
0
9
0
Order By: Relevance
“…Computed tomography adequately demonstrates morphology, location, and extent of cardiac neoplasms with a larger field view, while magnetic resonance signal intensity with contrast enhancement results in superior images identifying anatomy, blood flow, and cardiac function 16,17. [ 18 F]Fluorodeoxyglucose positron emission tomography imaging has recently been reported to reveal previously unsuspected cardiac involvement 18,19…”
Section: Discussionmentioning
confidence: 99%
“…Computed tomography adequately demonstrates morphology, location, and extent of cardiac neoplasms with a larger field view, while magnetic resonance signal intensity with contrast enhancement results in superior images identifying anatomy, blood flow, and cardiac function 16,17. [ 18 F]Fluorodeoxyglucose positron emission tomography imaging has recently been reported to reveal previously unsuspected cardiac involvement 18,19…”
Section: Discussionmentioning
confidence: 99%
“…In addition, some studies demonstrated 18 F-FDG PET/CT can not only be used for the localization and confirmation of tracer uptake in myocardium, but also can be used to monitor response to treatment. [6,12]…”
Section: Discussionmentioning
confidence: 99%
“…CT scan and MRI with gadolinium contrast injection were useful tools for demonstrating morphology, location, extension of disease, blood flow and cardiac function ( 14 , 15 ). FDG-PET imaging has recently reported to reveal previously unsuspected cardiac involvement ( 16 , 17 ).…”
Section: Discussionmentioning
confidence: 99%